Arundic acid a potential neuroprotective agent: biological development and syntheses

Area of Science:

• Neuroscience
• Pharmacology
• Medicinal Chemistry

Background:

• Arundic acid is investigated as a neuroprotective agent.
• It targets astrocyte activation and S-100β protein, implicated in neuronal death.
• No comprehensive reviews on its synthesis and neuroprotective development exist.

Purpose of the Study:

• To review the development of arundic acid as a neuroprotective agent.
• To summarize biological studies (in vitro and in vivo) and clinical trial outcomes.
• To consolidate information on synthetic routes for this non-natural compound.

Main Methods:

• Literature review of studies on arundic acid.
• Analysis of in vitro and in vivo experimental data.
• Summary of phase II clinical trial results for neurodegenerative diseases.

Main Results:

• Arundic acid demonstrates neuroprotection via astrocyte modulation.
• Phase II clinical trials for acute ischemic stroke and other neurodegenerative conditions have concluded.
• Various synthetic strategies for arundic acid have been reported over two decades.

Conclusions:

• Arundic acid is a promising neuroprotective agent with completed clinical trials.
• This review provides a consolidated overview of its therapeutic development and synthesis.
• Further research may explore its full potential in treating neurological disorders.